Opiate nerves mediate feline pyloric response to intraduodenal amino acids.
Intraluminal pressures and myoelectric activity were recorded from the feline antrum, pylorus, and duodenum in response to intraduodenal amino acid solutions. Mixed amino acids (0.02 mg/ml, 3.0 ml) increased the amplitude of pyloric contractions (59.7 +/- 7.9 mmHg) and pyloric spike activity (73.7 +/- 6.8% of slow waves with spike activity) compared with a saline control (P less than 0.001). The selectivity of these responses was determined with specific amino acids. L-Tryptophan (10 or 40 mM) produced a response similar to the mixed amino acid response, while L-phenylalanine or L-glycine (10 or 40 mM) had no effect. Intra-arterial tetrodotoxin, intraluminal ethyl aminobenzoate, or intravenous naloxone (1.0 mg/kg) abolished the pyloric responses to amino acids (P less than 0.02). Bilateral cervical vagotomy had no effect. Cholecystokinin octapeptide (CCK-OP) produced dose-dependent increases in the amplitude of pyloric contractions and in pyloric spike activity. The ED50 dose of CCK-OP (1.0 microgram/kg iv) gave an increase in pyloric pressure of 155.6 +/- 49.9 mmHg and in spike activity of 77.7 +/- 9.4%, similar to mixed amino acids or tryptophan. These effects of CCK-OP were not antagonized, however, by a dose of naloxone (1.0 mg/kg) that blocked the maximal pyloric response to leucine-enkephalin. We concluded intraduodenal mixed amino acids or tryptophan increase phasic, spike-dependent pyloric contractions in the cat via nonvagal, naloxone-sensitive neural pathways, phenylalanine, a structurally similar essential amino acid, had no effect on the feline gastroduodenal junction, and the pyloric responses to exogenous CCK-OP are mediated by pathways distinct from the responses to tryptophan or mixed amino acids.
D000596:Amino Acids / Q000494:pharmacology*; D000818:Animals; D002415:Cats; D004386:Duodenum / Q000378:metabolism*; D004723:Endorphins / Q000502:physiology; D005769:Gastrointestinal Motility; D009270:Naloxone / Q000494:pharmacology; D009434:Neural Pathways / Q000187:drug effects / Q000502:physiology; D010649:Phenylalanine / Q000494:pharmacology; D011708:Pylorus / Q000294:innervation* / Q000502:physiology; D012844:Sincalide / Q000494:pharmacology; D013268:Stimulation, Chemical; D014364:Tryptophan / Q000494:pharmacology
D000596:Amino Acids; D004723:Endorphins; D009270:Naloxone; D010649:Phenylalanine; D014364:Tryptophan; D012844:Sincalide